Wikidata

(Q43990453)

English

Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer

scientific article

In more languages

Statements

title
Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
24566467
retrieved
28 November 2017
author name string
Lee S Schwartzberg
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
24566467
retrieved
28 November 2017
Suprith Badarinath
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
24566467
retrieved
28 November 2017
Mark R Keaton
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
24566467
retrieved
28 November 2017
Barrett H Childs
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
24566467
retrieved
28 November 2017
publication date
27 December 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
24566467
retrieved
28 November 2017
page(s)
161-168
1 reference
stated in
Europe PubMed Central
PubMed ID
24566467
retrieved
28 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43990453&oldid=2105369230"